GlassScriptPhysician profile
Malihe Rivaz
NPI 1285995431
$2,174.91
in general payments reported to CMS, 2019-2025
30 companies · $85.82 in 2025
The $85.82 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,546 · 2020: $286 · 2021: $112 · 2022: $21.56 · 2023: $47.36 · 2024: $76.87 · 2025: $85.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $210.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $274.71 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $235.76 | 2019-2020 | |
| Medtronic USA, INC. | $193.50 | 2019 | |
| Amgen INC. | $177.02 | 2019-2025 | Uplizna |
| Alexion Pharmaceuticals, INC. | $127.56 | 2019-2020 | |
| Ucb, INC. | $123.48 | 2019-2020 | |
| Abbvie INC. | $113.47 | 2021-2025 | |
| Celgene Corporation | $102.02 | 2020-2021 | |
| Abbott Laboratories | $95.59 | 2023-2024 | Infinity |
| Genzyme Corporation | $85.39 | 2019 | |
| Genentech USA, INC. | $79.67 | 2019 | |
| Acorda Therapeutics, INC | $67.59 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $58.75 | 2019 | |
| Aquestive Therapeutics, INC. | $48.83 | 2019 | |
| Mdd US Operations, LLC | $41.66 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $40.71 | 2019-2020 | |
| Zyla Life Sciences, INC. | $37.23 | 2019 | |
| Assertio Therapeutics, INC. | $33.69 | 2019-2020 | |
| Tanabe Pharma America, INC. | $31.83 | 2019 | |
| Ceribell, INC. | $28.64 | 2024 | Pocket Eeg Device |
| Emd Serono, INC. | $27.36 | 2019 | |
| Arbor Pharmaceuticals, INC. | $24.97 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $22.37 | 2020 | |
| Catalyst Pharmaceuticals, INC. | $18.06 | 2019 | |
| Sanofi-Aventis U.S. LLC | $18.05 | 2020 | |
| Eisai INC. | $14.34 | 2019 | |
| Avanir Pharmaceuticals, INC. | $13.96 | 2019 | |
| Amneal Pharmaceuticals LLC | $13.21 | 2019 | |
| Upsher-Smith Laboratories LLC | $13.16 | 2020 | |
| Pfizer INC. | $12.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Malihe Rivaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.